financetom
Business
financetom
/
Business
/
Shift4 Payments Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Shift4 Payments Q3 Adjusted Earnings, Revenue Rise
Nov 6, 2025 5:31 AM

08:15 AM EST, 11/06/2025 (MT Newswires) -- Shift4 Payments ( FOUR ) reported Q3 adjusted earnings Thursday of $1.47 per share, up from $1.39 a year earlier.

Analysts surveyed by FactSet expected $1.44.

Revenue for the quarter ended Sept. 30 was $1.18 billion, up from $909.2 million a year earlier.

Analysts polled by FactSet expected $1.18 billion.

The company's shares were up 5.1% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Utility PG&E beats Q3 adjusted EPS estimates, narrows FY profit forecast
Utility PG&E beats Q3 adjusted EPS estimates, narrows FY profit forecast
Oct 23, 2025
Overview * PG&E ( PCG ) Q3 operating revenue missed analyst expectations * Adjusted EPS for Q3 beats analyst estimates * GAAP EPS for Q3 increased to $0.37 from $0.27 in 2024 Outlook * PG&E ( PCG ) narrows 2025 non-GAAP core EPS guidance to $1.49-$1.51 * Company initiates 2026 non-GAAP core EPS guidance of $1.62-$1.66 * PG&E ( PCG...
Thermal tech firm Gentherm posts higher Q3 revenue, raises guidance 
Thermal tech firm Gentherm posts higher Q3 revenue, raises guidance 
Oct 23, 2025
Overview * Gentherm ( THRM ) Q3 revenue rises 4.1% to $387 mln, adjusted EBITDA beats estimates * Company secured $745 mln in automotive new business awards in Q3 * Gentherm ( THRM ) raises 2025 full-year revenue guidance midpoint Outlook * Gentherm ( THRM ) raises full-year 2025 revenue guidance to $1.47 bln-$1.49 bln * Adjusted EBITDA margin guidance...
India's Cipla signs pact with Lilly to sell weight loss drug tirzepatide in India
India's Cipla signs pact with Lilly to sell weight loss drug tirzepatide in India
Oct 23, 2025
Oct 23 (Reuters) - Indian drugmaker Cipla signed an agreement with Eli Lilly ( LLY ) to sell tirzepatide, the active ingredient in the U.S. company's blockbuster weight-loss drug Mounjaro, in India, the companies said on Thursday. ...
China trade spat threatens Wisconsin's 'Napa Valley' of ginseng
China trade spat threatens Wisconsin's 'Napa Valley' of ginseng
Oct 23, 2025
WAUSAU, Wisconsin (Reuters) -The cool woodlands of central Wisconsin boast soils packed with Ice Age mineral deposits that make the area perfect for the cultivation of ginseng, a medicinal root that has been exported to Asia for more than 300 years. Sliced and used in tea or ground into capsules, ginseng root is touted as an energy- and immunity-booster that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved